Immunity
Volume 34, Issue 5, 27 May 2011, Pages 729-740
Journal home page for Immunity

Article
B7-H2 Is a Costimulatory Ligand for CD28 in Human

https://doi.org/10.1016/j.immuni.2011.03.014Get rights and content
Under an Elsevier user license
open archive

Summary

CD28 and CTLA-4 are cell surface cosignaling molecules essential for the control of T cell activation upon the engagement of their ligands B7-1 and B7-2 from antigen-presenting cells. By employing a receptor array assay, we have demonstrated that B7-H2, best known as the ligand of inducible costimulator, was a ligand for CD28 and CTLA-4 in human, whereas these interactions were not conserved in mouse. B7-H2 and B7-1 or B7-2 interacted with CD28 through distinctive domains. B7-H2-CD28 interaction was essential for the costimulation of human T cells' primary responses to allogeneic antigens and memory recall responses. Similar to B7-1 and B7-2, B7-H2 costimulation via CD28 induced survival factor Bcl-xL, downregulated cell cycle inhibitor p27kip1, and triggered signaling cascade of ERK and AKT kinase-dependent pathways. Our findings warrant re-evaluation of CD28 and CTLA-4's functions previously attributed exclusively to B7-1 and B7-2 and have important implications in therapeutic interventions against human diseases.

Highlights

► B7-H2 is a functional ligand for CD28 and potentially for CTLA-4 in human ► B7-H2 binds CD28 via a nonoverlapping domain as B7-1 and B7-2 ► B7-H2-CD28 interaction delivers signals through ERK- and AKT-dependent pathways

Cited by (0)